1,417
Views
4
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Treatment sequence of lenalidomide and hypomethylating agents and the impact on clinical outcomes for patients with myelodysplastic syndromes

, , &
Pages 2050-2055 | Received 16 Aug 2018, Accepted 14 Nov 2018, Published online: 14 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Russell Lewis, Jan Philipp Bewersdorf & Amer M Zeidan. (2021) Clinical Management of Anemia in Patients with Myelodysplastic Syndromes: An Update on Emerging Therapeutic Options. Cancer Management and Research 13, pages 645-657.
Read now

Articles from other publishers (3)

Josephine Lucero, Salman Al-Harbi & Karen W. L. Yee. (2023) Management of Patients with Lower-Risk Myelodysplastic Neoplasms (MDS). Current Oncology 30:7, pages 6177-6196.
Crossref
Sara Mongiorgi, Alessia De Stefano, Stefano Ratti, Valentina Indio, Annalisa Astolfi, Irene Casalin, Andrea Pellagatti, Stefania Paolini, Sarah Parisi, Michele Cavo, Andrea Pession, James A. McCubrey, Pann-Ghill Suh, Lucia Manzoli, Jacqueline Boultwood, Carlo Finelli, Lucio Cocco & Matilde Y. Follo. (2023) A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes. Clinical Epigenetics 15:1.
Crossref
Olivier Tredan, Marie Laurent, Melina Gilberg, Rim Ghorbal, Alexandre Vainchtock, Joannie Lortet-Tieulent, Martin Prodel & Julien Dupin. (2022) Innovative Approach for a Typology of Treatment Sequences in Early Stage HER2 Positive Breast Cancer Patients Treated With Trastuzumab in the French National Hospital Database. Cancer Informatics 21, pages 117693512211351.
Crossref